Cancer Center– A Cancer Center Designated by
the National Cancer Institute

Clinical Trials in the Category "Neoplasms, Germ Cell and Embryonal"

Drug Intervention Trials that are Recruiting

Study Title
 Principal Investigator Disease Category
Combination Chemotherapy and Surgery With or Without Isotretinoin in Treating Young Patients With Neuroblastoma Dr. Neyssa Maria Marina
 Neuroblastoma
A Study of Pemetrexed in Children With Recurrent Cancer Dr. Neyssa Maria Marina
 Osteosarcoma
Neuroblastoma
Medulloblastoma
Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk Neuroblastoma Dr. Neyssa Marina
 Neuroblastoma
Combination Chemotherapy in Treating Young Patients With Recurrent or Resistant Malignant Germ Cell Tumors Dr. Neyssa Marina
 Ovarian Cancer
Neoplasms, Germ Cell and Embryonal
Intravenous Fenretinide in Treating Young Patients With Recurrent or Resistant Neuroblastoma Clare J. Twist M.D.
 Neuroblastoma
Irinotecan and Vincristine for Radiosensitization of 131I-MIBG Therapy for High-Risk Neuroblastoma Clare J. Twist M.D.
 Neuroblastoma
SARC 009: A Phase II Trial of Dasatinib in Advanced Sarcomas Kristen N. Ganjoo
 Hemangiopericytoma
Nerve Sheath Neoplasms
Rhabdomyosarcoma
Chordoma
Melphalan and Buthionine Sulfoximine Followed by Stem Cell Transplantation in Children With Resistant or Recurrent Neuroblastoma Clare J. Twist M.D.
 Neuroblastoma
Isotretinoin With or Without Monoclonal Antibody, Interleukin-2, and Sargramostim Following Stem Cell Transplantation in Treating Patients With Neuroblastoma Dr. Neyssa Marina
 Neuroblastoma
Low-Dose Radiation Therapy and Combination Chemotherapy Following Surgery in Treating Children With Newly Diagnosed Primitive Neuroectodermal Tumor or Medulloblastoma Paul Graham Fisher
 Central Nervous System Neoplasms
Brain Cancer
Neuroectodermal Tumors
Medulloblastoma
Surgery and Combination Chemotherapy in Treating Children With Extracranial Germ Cell Tumors Dr. Neyssa Marina
 Ovarian Cancer
Neoplasms, Germ Cell and Embryonal
Comparison of Radiation Therapy Regimens in Combination With Chemotherapy in Treating Young Patients With Newly Diagnosed Standard-Risk Medulloblastoma Dr. Neyssa Marina
 Central Nervous System Neoplasms
Brain Cancer
Medulloblastoma
Iodine I 131 Metaiodobenzylguanidine, Combination Chemotherapy, and Radiation Therapy in Treating Patients Who Are Undergoing an Autologous Peripheral Stem Cell or Bone Marrow Transplant for Relapsed or Refractory Neuroblastoma Clare J. Twist M.D.
 Neuroblastoma
Ixabepilone in Treating Young Patients With Refractory Solid Tumors Dr. Neyssa Marina
 Sarcoma
Wilms Tumor
Neuroblastoma


Other Trials that are Recruiting

Study Title
 Principal Investigator Disease Category
Phase 2 Study of Nimotuzumab in Pediatric Recurrent Diffuse Intrinsic Pontine Glioma Paul Graham Fisher
 Glioma
Study of Late-Occurring Complications in Childhood Cancer Survivors Dr. Neyssa Marina
 Leukemia
Sarcoma
Retinoblastoma
Lymphoma
Retinal Neoplasms

Trials not Recruiting

Study Title
 Principal Investigator Disease Category
Zoledronic Acid (ZOMETA) With Cyclophosphamide With Neuroblastoma and Cortical Bone Involvement
(No longer recruiting) 		Clare J. Twist M.D.
 Neuroblastoma
Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma
(No longer recruiting) 		Dr. Neyssa Marina
 Central Nervous System Neoplasms
Ependymoma
Brain Cancer
Neoadjuvant Chemotherapy With or Without Second-Look Surgery Followed by Radiation Therapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Intracranial Germ Cell Tumors
(No longer recruiting) 		Dr. Neyssa Marina
 Central Nervous System Neoplasms
Neoplasms, Germ Cell and Embryonal
Brain Cancer
hu14.18-Interleukin-2 Fusion Protein in Treating Young Patients With Recurrent or Refractory Neuroblastoma
(Completed) 		Dr. Neyssa Marina
 Neuroblastoma
Radiation Therapy, Temozolomide, and Lomustine in Treating Young Patients With Newly Diagnosed Gliomas
(No longer recruiting) 		Dr. Neyssa Marina
 Central Nervous System Neoplasms
Brain Cancer
Glioma
Vorinostat With or Without Isotretinoin in Treating Young Patients With Recurrent or Refractory Solid Tumors, Lymphoma, or Leukemia
(No longer recruiting) 		Dr. Neyssa Marina
 Leukemia
Lymphoma
Neuroblastoma
Medulloblastoma


The physicians of the Stanford Cancer Center are engaged in more than 250 clinical trials.  Contracts with some of our clinical trial sponsors prevent us from listing specific trial information on our web site. Please contact the Stanford Cancer Clinical Trials Office at 650-498-7061 for information about additional open clinical trials.

Stanford Medicine Resources:

Footer Links: